WHO ICTRP trial
Selective depletion of C-reactive protein by means of therapeutic apheresis…
DRKS00014265 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00014265 |
|---|---|
| Public title | Selective depletion of C-reactive protein by means of therapeutic apheresis (CRP-apheresis) in acute pancreatitis |
| Scientific title | Selective depletion of C-reactive protein by means of therapeutic apheresis (CRP-apheresis) in acute pancreatitis - CAPRI1 |
| Primary sponsor | Pentracor GmbH |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | K85.80;K85.80 |
| Interventions | Group 1: 20 patients with moderate or severe acute pancreatitis receive a maximum of 7 apheresis treatments at intervals of 24±12 hours. |
| Registration date | Dec 3, 2018 |
| Target size | 20 |
| Secondary IDs | U1111-1210-5221;CIV-17-12-022444 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: